PPM1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.25439999948607E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.89889995236581E-09 |
Normal-vs-Stage2 |
2.83740000051047E-07 |
Normal-vs-Stage3 |
6.615400E-04 |
Normal-vs-Stage4 |
1.793980E-04 |
Stage1-vs-Stage2 |
9.736400E-01 |
Stage1-vs-Stage3 |
2.667000E-01 |
Stage1-vs-Stage4 |
9.110200E-01 |
Stage2-vs-Stage3 |
3.355600E-01 |
Stage2-vs-Stage4 |
9.428600E-01 |
Stage3-vs-Stage4 |
3.377600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.75590000042847E-07 |
Normal-vs-AfricanAmerican |
1.31289999982798E-08 |
Normal-vs-Asian |
4.50540005303424E-09 |
Caucasian-vs-AfricanAmerican |
2.020200E-01 |
Caucasian-vs-Asian |
9.815700E-03 |
AfricanAmerican-vs-Asian |
9.588400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.42920136731095E-11 |
Normal-vs-Female |
6.579300E-03 |
Male-vs-Female |
2.900900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.65330000000608E-05 |
Normal-vs-Extreme_Weight |
1.50173999999836E-05 |
Normal-vs-Obese |
2.19849999982813E-07 |
Normal-vs-Extreme_Obese |
3.27750049322617E-10 |
Normal_Weight-vs-Extreme_Weight |
6.812600E-01 |
Normal_Weight-vs-Obese |
8.506200E-01 |
Normal_Weight-vs-Extreme_Obese |
1.861550E-02 |
Extreme_Weight-vs-Obese |
7.384800E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.010980E-01 |
Obese-vs-Extreme_Obese |
6.997900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.829100E-04 |
Normal-vs-Age(41-60Yrs) |
4.26850000001533E-06 |
Normal-vs-Age(61-80Yrs) |
5.56489999969934E-07 |
Normal-vs-Age(81-100Yrs) |
6.01290000012966E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.254200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.088200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.149600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.364800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.048410E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.325400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.13310000166211E-09 |
Normal-VS-Type2 PRCC |
2.43850000192225E-08 |
Normal-VS-KIRP CIMP |
4.833700E-02 |
Normal-VS-Unclassified PRCC |
7.242700E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.351960E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.243000E-04 |
Type1 PRCC-VS-Unclassified PRCC |
5.961800E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.053360E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.857600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.026000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.85329995794348E-09 |
Normal-vs-N1 |
7.168300E-04 |
Normal-vs-N2 |
7.977000E-03 |
N0-vs-N1 |
2.339400E-01 |
N0-vs-N2 |
9.150600E-01 |
N1-vs-N2 |
5.874600E-01 |
|
|